Carsten Müller-Tidow Selected Research

Carsten Müller-Tidow Research Topics

Disease

106	Neoplasms (Cancer) 05/2024 - 07/2002
99	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 07/2002
45	Leukemia 11/2023 - 07/2002
32	Multiple Myeloma 01/2024 - 03/2006
15	Hematologic Neoplasms (Hematological Malignancy) 05/2024 - 08/2007
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 02/2003
14	Infections 05/2024 - 04/2005
14	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2003
12	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 04/2015
10	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023 - 12/2011
9	Acute Promyelocytic Leukemia 12/2021 - 11/2006
8	Disease Progression 01/2023 - 12/2013
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 08/2008
8	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2003
7	Immunoglobulin Light-chain Amyloidosis 01/2024 - 11/2018
7	Inflammation (Inflammations) 12/2023 - 12/2013
6	Lymphoma (Lymphomas) 02/2024 - 12/2011
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2021 - 02/2007
5	COVID-19 05/2024 - 10/2020
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 01/2017
5	Sarcoma (Soft Tissue Sarcoma) 02/2022 - 06/2015
5	Testicular Neoplasms (Testicular Cancer) 02/2022 - 02/2003
4	Carcinogenesis 01/2021 - 02/2003
4	Ewing Sarcoma (Sarcoma, Ewing) 11/2017 - 11/2015
4	Carcinoma (Carcinomatosis) 01/2017 - 02/2003
4	Infarction (Infarctions) 01/2017 - 03/2013
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2012 - 07/2003
3	Body Weight (Weight, Body) 10/2023 - 11/2017
3	Amyloidosis 01/2023 - 03/2018
3	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2010
3	Residual Neoplasm 01/2023 - 02/2012
3	Paraproteinemias (Monoclonal Gammopathy) 11/2022 - 11/2018
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021 - 01/2019
3	Anemia 02/2018 - 06/2015
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2024 - 02/2021
2	Rheumatic Diseases (Rheumatism) 04/2024 - 03/2018
2	Cardiotoxicity 03/2024 - 01/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 12/2015

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 11/2022 - 07/2002
24	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2017
15	Transcription Factors (Transcription Factor)IBA 12/2023 - 04/2004
13	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2007
12	Messenger RNA (mRNA)IBA 01/2017 - 07/2002
12	Phosphotransferases (Kinase)IBA 01/2016 - 02/2004
11	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 02/2007
9	ChromatinIBA 12/2023 - 03/2008
9	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2023 - 01/2015
9	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 04/2003
8	CytokinesIBA 01/2024 - 10/2004
8	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 08/2008
8	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
8	Cyclin A1IBA 01/2009 - 08/2002
7	AntigensIBA 01/2024 - 01/2012
7	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023 - 01/2021
7	Lenalidomide (CC 5013)FDA Link 11/2023 - 08/2008
7	AntibodiesIBA 10/2023 - 03/2015
7	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2012
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012 - 03/2005
6	venetoclaxIBA 01/2023 - 01/2020
6	Small Interfering RNA (siRNA)IBA 12/2022 - 03/2008
5	LigandsIBA 11/2023 - 12/2006
5	SteroidsIBA 01/2022 - 01/2018
5	tyrosine receptor (receptor, tyrosine)IBA 01/2016 - 02/2004
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 12/2013
4	Immunomodulating AgentsIBA 08/2023 - 10/2018
4	MethyltransferasesIBA 12/2022 - 09/2013
4	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 09/2012
4	Thromboplastin (Tissue Factor)IBA 01/2017 - 03/2013
4	MicroRNAs (MicroRNA)IBA 04/2014 - 01/2008
4	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 08/2008
4	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 06/2010 - 12/2004
4	CyclinsIBA 01/2009 - 09/2003
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 01/2021
3	B-Cell Maturation AntigenIBA 01/2024 - 10/2020
3	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2024 - 10/2021
3	Membrane Proteins (Integral Membrane Proteins)IBA 12/2023 - 03/2013
3	Bortezomib (Velcade)FDA Link 11/2023 - 01/2017
3	Proteasome InhibitorsIBA 10/2023 - 01/2022
3	daratumumabIBA 10/2023 - 01/2020
3	ProteomeIBA 10/2022 - 11/2006
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2004
3	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 01/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 03/2015
3	Sorafenib (BAY 43-9006)FDA Link 12/2015 - 06/2012
3	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 11/2015 - 03/2005
3	Rituximab (Mabthera)FDA Link 12/2013 - 04/2010
3	CCAAT-Enhancer-Binding Protein-alphaIBA 08/2012 - 03/2010
3	EphB6 ReceptorIBA 01/2012 - 07/2009
2	Long Noncoding RNAIBA 05/2024 - 09/2014
2	Gemtuzumab (Mylotarg)FDA Link 02/2024 - 01/2022
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2024 - 01/2023

Therapy/Procedure

72	Therapeutics 05/2024 - 07/2003
33	Drug Therapy (Chemotherapy) 10/2023 - 08/2004
29	Stem Cell Transplantation 01/2024 - 09/2012
15	Immunotherapy 10/2023 - 10/2004
8	Cell Transplantation 03/2024 - 07/2011
7	Hematopoietic Stem Cell Transplantation 02/2024 - 01/2018
5	Homologous Transplantation 02/2022 - 07/2011
4	Photopheresis 02/2024 - 01/2018
4	Transplantation 02/2021 - 06/2010